Document is current

Article History

Accepted: 25 August 2024

First Online: 18 September 2024

Declarations

:

: This study was funded by Gilead Sciences, Inc.

: Elijah J. Weber, Islam R. Younis, Cara Nelson, and Ahmed A. Othman were employees of Gilead Sciences, Inc. at the time of this work and may own stock in Gilead Sciences, Inc. Ann R. Qin and Timothy R. Watkins are employees of, and may own stock in, Gilead Sciences, Inc.

: The study protocol was reviewed and approved by an IRB (Salus IRB; 2111 West Braker Lane, Suite 400, Austin, TX 78758, USA).

: All participants provided written informed consent before study participation.

: All authors approved this manuscript for publication.

: Gilead Sciences shares anonymized individual patient data upon request, or as required by law or regulation, with qualified external researchers based on submitted curriculum vitae and reflecting non-conflicts of interest. The request proposal must also include a statistician. Approval of such requests is at Gilead Science's discretion and is dependent on the nature of the request, the merit of the research proposed, the availability of the data, and the intended use of the data. Data requests should be sent to datarequest@gilead.com.

: CN and ARQ designed the study. EJW, IRY, CN, ARQ, TRW, and AAO analyzed and interpreted the data and drafted the manuscript. All authors revised and approved the final version of the manuscript submitted for publication.